Loading data for UTMD — first visit, this takes a few seconds.

提醒

Utah Medical Products Inc... (UTMD)

NasdaqGS: UTMD · 即時價格 · USD

72.00

+1.79 (2.55%)

收盤時： Aug 18, 2026, 3:59 PM

2.55% (1D)

買價	51.27
市值	229.23M
營收 (ttm)	36.11M
淨利（ttm）	10.49M
貝塔	0.36
EPS (ttm)	3.28
本益比（ttm）	21.43
正向 PE	n/a
P/B (ttm)	1.90
P/S (ttm)	6.35
Earnings Date	Oct 22, 2026

賣價	91.78
成交量	46,769
20 日平均成交量	21,729
打開	70.80
上一頁關閉	70.21
日間範圍	70.80 - 72.45
52 週範圍	53.66 - 75.75
分析師	n/a
目標價	n/a
股利	$1.24 (1.77%)
Ex-股利日期	2026年9月17日

關於UTMD

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PAL...

[閱讀更多]

工業 Medical Instruments & Supplies

部門 Healthcare

IPO 日期 Mar 8, 1999

員工 140

證券交易所 NasdaqGS

股票代號 UTMD

網站 https://www.utahmed.com

完整的公司簡介

財務表現

Utah Medical Products 在 2025 年的營收為 38.52M，較前一年的 40.9M 減少 -5.83%。淨利為 11.29M，較前期減少 -18.65%。

財務報表

獲利驚喜

Utah Medical Products 已於 Apr 24, 2014 公布季度財報：

營收的 n/a 錯過估計 $0, 與 -100.00% YoY 下降.

EPS 的 0.72 錯過估計 -0.07, 與 -1.37% YoY 下降.

下次財報發布

Utah Medical Products Inc. 定於發布財報 Oct 22, 2026, 開市前。
分析師預估營收 ... 升級

新聞動態

2 週前 · Zacks

Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses

UTMD's Q2 earnings per share decline 10.1% year over year, while quarterly revenues face pressure from lost customers and slower new business growth.

2 月前 · Zacks

The Zacks Analyst Blog Highlights Berkshire, Eli Lilly, Walmart, Universal Health Realty Income and Utah

BRK.B, LLY and WMT headline top analyst reports, highlighting business strengths, growth drivers and key risks shaping their outlooks.

2 月前 · Zacks

Top Analyst Reports for Berkshire Hathaway, Eli Lilly & Walmart

Berkshire Hathaway, Eli Lilly and Walmart headline new analyst reports, highlighting growth drivers, opportunities and key risks shaping their outlooks.

3 月前 · Zacks

Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs

UTMD reports a year-over-year decline in Q1 earnings per share and sales, pressured by lost distributor business and higher costs, despite improved margins and a strong balance sheet.

4 月前 · Zacks

Utah Medical Gains 32% in a Year: Should You Buy the Stock?

UTMD's niche leadership, global footprint, and strong cash generation position it to benefit from rising demand for high-quality maternal and neonatal healthcare solutions.

第 1 頁，共 2 頁

Utah Medical Products Inc... (UTMD)